Is Avatrombopag/Sukesin covered by medical insurance?

Avatrombopag/Avatrombopag, also known as Sucoxin in the Chinese market, is an oral drug used to treat idiopathic thrombocytopenia (ITP) and other diseases. In recent years, due to its clinical effectiveness and safety, avatrombopag has gradually attracted the attention of the medical community and patients. Regarding the issue of whether they are included in medical insurance, the adjustment and update of the national drug catalog in recent years has gradually brought some new drugs into the scope of medical insurance reimbursement.

Up to now, avatrombopag has been included in medical insurance to a certain extent, and the specific situation varies depending on regions and medical insurance policies. In some provinces or cities, basic medical insurance may already be included, while in other places it may not yet be fully covered. Its reimbursement conditions are limited to adult patients with chronic liver disease-related thrombocytopenia who undergo elective diagnostic procedures or surgeries. Therefore, before using this drug, patients need to consult their local medical insurance department or hospital to confirm whether it can be reimbursed.

After reimbursement by medical insurance, the cost of avatrombopag will be significantly reduced. Originally, the market price of this drug was relatively high. The common specifications are 15 tablets of 20mg and 10 tablets of 20mg. Usually, a box costs about RMB 7,000. However, the specific reimbursement ratio and patient out-of-pocket costs depend on local medical insurance policies. In some places, patients may only have to pay out-of-pocket ranging from a few hundred yuan to more than a thousand yuan after medical insurance reimburses them, which undoubtedly reduces the financial burden for many patients.

Medical insurance reimbursement policies are also constantly being adjusted, and there may be new changes. Therefore, when receiving treatment, in addition to paying attention to the efficacy of the drug, it is particularly important for patients to keep abreast of the relevant policies and reimbursement status of medical insurance. By communicating with medical staff, patients can obtain more detailed information, including specific reimbursement procedures and required materials. These will help patients make better use of medical insurance resources and effectively control treatment costs.